Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

HISTORICAL FACTS: Looking into avid bioservices s return on capital employed - Caught on Camera

According to Benzinga Pro, during Q4, Avid Bioservices (NASDAQ:CDMO) earned $115.60 million, a 5042.26% increase from the preceding quarter. Avid Bioservices's sales decreased to $31.23 million, a 0.9% change since Q3. In Q3, Avid Bioservices brought in $31.51 million in sales but only earned $2.25 million.

What Is Return On Capital Employed?

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.